Structure and duties of Blood service

Size: px
Start display at page:

Download "Structure and duties of Blood service"

Transcription

1 NATIONAL CENTER FOR TRANSFUSION MEDICINE Prevalence of infectious diseases among Mongolian blood donors Namjil Erdenebayar General director of The National Center for Transfusion Medicine, Mongolia NCTM, Sukhbaatar district, Peace Enkhtaivan(Peace) Avenue 13, Ulaanbaatar, Mongolia Ub-14210, post-48, box-22сүт, Tel/Fax: , Structure and duties of Blood service MOHS NCTM Blood Banks/26/ Ministry of Health is responsible for blood service: Encouraging the Blood Service in order to approve and implement the principles, guidelines related to the blood safety. Ensuring professional methods for activities of implementing the Mongolian Government policy. The National Center for Transfusion Medicine, which is a specialized professional service that deals with producing safe and sample blood supplies to local and private hospitals throughout Mongolia as well as continually managing, guiding and embracing all Hospital Blood banks. Blood Banks provide the hospitals in rural areas with necessary blood and blood products and specialized management and guidance for soum level. 1

2 Legal aspects Blood collection from non-remunerated blood donors was introduced in 1994 and legislated by the Ministry of Health in The Donor Law was approved in 2000 by the Great Khural (Parliament) of Mongolia and revised in The Government policy on Improving provision and supply with safe blood and blood products was approved in 2007 by the Great Khural. The Plan of Action for to implement the Government policy for improvement of provision with safe blood and blood products was approved in 2008 by article 111 of Government Resolution. The NCTM have 26 blood banks in 21 province 2

3 Chronology of screening for TTI in Mongolia Implementation of hepatitis B surface antigen (HBsAg) in routine screening of blood donors 1991-Implementation of HIV antibody (Anti-HIV) in routine screening of blood donors 1997-Implementation of hepatitis C antibody (Anti-HCV ) in routine screening of blood donors implementation of ELISA method for syphilis PCR technology has been introduced in the NCTM to screen for HBV, HCV and HIV. WHO recommendation Screening of all blood donations should be mandotory HIV-I/II, HBV, HCV, Syphilis Depending on the geographic location, demographic dynamics, percentage of foreign citizens in the population Mongolia HIV-I/II, HBV, HCV, Syphilis Inaddition CMV, HTLV-I/II, EBV, HHV, Parvovirus-B19, West-Nile virus, Chikungunya virus 3

4 Infectious testing method in blood service At soum level At aimag level At NCTM 100% with RAPID TESTS ELISA/Chemiluminescence ELISA and PCR Order 02, 2016 of Health Minister for improving blood safety Algorithm for TTI screening tests in blood donor 2010-International algorithm has been introduced for TTI tests of blood donors approved by the WHO. 4

5 The prevalence Hepatitis B / / hepatitis B Hepatitis B viral infection among blood donors in Mongolia 6,0% 5,0% 4,0% 3,0% 2,0% 1,0% Blood Bank 4,8% 4,7% 4,0% 3,7% 2,4% NCTM 4,4% 4,1% 4,6% 3,7% 2,2% In 2015 the prevalence of hepatitis B viral infection among blood donors decreased 2 fold compared to 2011 The prevalence Hepatitis C / / Hepatitis C viral infection among blood donors in Mongolia prevalence 4,0% 3,5% 3,0% 2,5% 2,0% 1,5% 1,0% 0,5% Blood bank 3,4% 3,0% 2,7% 2,3% 2,3% NCTM 3,6% 2,6% 3,3% 2,6% 2,7% In 2015 the prevalence of hepatitis C viral infection among blood donors decreased about 1% compared to

6 The prevalence Syphilis / / prevalence % 3,5% 3,0% 2,5% 2,0% 1,5% 1,0% 0,5% The prevalence of syphilis among blood donors Blood bank 1,5% 3,2% 3,0% 2,4% 2,3% NCTM 1,7% 2,8% 3,2% 3,2% 2,7% Since 2010 introduced the Syphilis Ab test is a solid phase ELISA for qualitative detection of antibodies Ig G and Ig M against Treponema Pallidum. Therefore, prevalence of syphilis among blood donors has increasing in past years. The prevalence HIV / / 2 2 prevalence Blood bank 0,007% 0,002% 0,01% 0,006% NCTM 0,003% 0,006% 0,01% The prevalence of HIV infection among blood donors only 0-2 cases reported in year. 6

7 Elimination by TTI ,0% 30,8% 29,3% ,1% ,0% 20,7% ,4% 17,7% 15,0% 10,4% 9,6% 8,7% 8,1% 7,2% 1 5,0% Total tested blood donor Elimination by TTI /by percent/ Screening for PCR positive % 0,70% 0,60% 0,50% 0,40% 0,30% 0,20% 0,10% The results of PCR 0,00% HBV DNA 0,58% 0,23% 0,23% 0,18% HCV RNA 0,07% 0,04% 0,01% 0,02% Nucleic acid amplification testing shortens WP, thereby offering blood centers a much higher sensitivity for detecting viral infections. We used to PCR for whom with absence serological markers of infection. Positive results of PCR are decreasing in last years. 7

8 Study of Screening for HTLV-I/II infection HTLV-I/II specific IgG antibodies not detected all 716 studied blood donors. HTLV-I/II specific IgG antibodies and nationality Хүснэгт 2. HTLV-I/II Ig G Mongolian Another country positive - - negative 100% (709) 100%(7) Total 100% (709) 100%(7) B.Tsogbadrakh, N.Erdenebayar 2014 The prevalence of CMV among blood donors CMV - specific IgG antibodies were detected in 99.2 % (710) of the studied subjects and, CMV - specific IgM antibodies in 0.1 % ( 1 ). Screening for CMV- IgG and CMV- IgM CMV IgG CMV IgM Positive Negative Positive Negative 0 6 B.Tsogbadrakh, N.Erdenebayar 2014 Total

9 Quality assurance for TTI 2005-started participate to EQAS program for TTI organized by an Australian NRL started a national EQAS program for TTI test and involved laboratories of Ulaanbaatar and Rural areas /MEQAS/. Further To implement of PCR technology to donor screening for TTI of aimag s BB step by step. To implement accreditation ISO 9001 :

10 THANKS FOR YOUR ATTENTION SAFE BLOOD SAVE А LIFE 10

Screening donors and donations for transfusion transmissible infectious agents. Alan Kitchen

Screening donors and donations for transfusion transmissible infectious agents. Alan Kitchen Screening donors and donations for transfusion transmissible infectious agents Alan Kitchen Aim Not to teach you microbiology To provide and awareness of the big picture To provide an understanding of

More information

EC CERTIFICATE. National Institute for Biological Standards and Control (NIBSC) Blanche Lane South Mimms Potters Bar Hertfordshire EN6 3QG UK

EC CERTIFICATE. National Institute for Biological Standards and Control (NIBSC) Blanche Lane South Mimms Potters Bar Hertfordshire EN6 3QG UK National Institute for Biological Standards and Control (NIBSC) EC Certificate - Full Quality Assurance System Approval Certificate Annex IV (excluding sections 4 and 6) of Council Directive 98/79/EC on

More information

Meeting Report. Technical Meeting on Raising Awareness, Surveillance, Prevention and Management of Viral Hepatitis in Mongolia

Meeting Report. Technical Meeting on Raising Awareness, Surveillance, Prevention and Management of Viral Hepatitis in Mongolia Meeting Report Technical Meeting on Raising Awareness, Surveillance, Prevention and Management of Viral Hepatitis in Mongolia 12 September 2014 Ulaanbaatar, Mongolia Participants of the Technical Meeting

More information

Impact of Testing Strategies to Reduce Transmission Risk for HBV. Ravi Reddy, M Vermeulen South African National Blood Service (SANBS) 29 July 2013

Impact of Testing Strategies to Reduce Transmission Risk for HBV. Ravi Reddy, M Vermeulen South African National Blood Service (SANBS) 29 July 2013 Impact of Testing Strategies to Reduce Transmission Risk for HBV Ravi Reddy, M Vermeulen South African National Blood Service (SANBS) 29 July 2013 Overview of SANBS SANBS is a private not for profit company

More information

Non-reproductive tissues and cells

Non-reproductive tissues and cells Colour key Minimum requirements as set out in Directive 2004/23/EC More stringent testing - legally binding on national level More stringent testing - recommended on national level Not legally binding

More information

Non-reproductive tissues and cells Recommending authority/ association

Non-reproductive tissues and cells Recommending authority/ association Colour key Minimum requirements as set out in Directive 2004/23/EC More stringent - legy binding More stringent - recommended Not legy binding and not recommended Tested pathogen Donor test/ technique

More information

Non-reproductive tissues and cells

Non-reproductive tissues and cells Ministry of Health: Institute for Transplantation and Biomedicine / Colour key VIRAL HIV 1 and HIV 2 Hepatitis B Minimum requirements as set out in Directive 2004/23/EC More stringent - legy binding More

More information

Accreditation in the Philippines

Accreditation in the Philippines 2015/LSIF/FOR/014 Accreditation in the Philippines Submitted by: Philippines 2 nd APEC Blood Supply Chain Policy Forum Anaheim, United States 23 October 2015 3/11/2015 ACCREDITATION in THE PHILIPPINES

More information

Non-reproductive tissues and cells

Non-reproductive tissues and cells Colour key Tested pathogen VIRAL Minimum requirements as set out in Directive 2004/23/EC More stringent testing - legy binding on national level More stringent testing - recommended on national level Not

More information

Non-reproductive tissues and cells Recommending authority/ association

Non-reproductive tissues and cells Recommending authority/ association Colour key Minimum requirements as set out in Directive 2004/23/EC More stringent - legally binding More stringent - recommended Not legally binding and not recommended Non-reproductive tissues and cells

More information

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Schedule of Accreditation 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK National Infection Service, Public Health England Colindale 61 Colindale Avenue London NW9 5EQ Contact: Dr Sanjiv

More information

Donor Screening in The Region. Vincini GA NRL, Melbourne, Australia

Donor Screening in The Region. Vincini GA NRL, Melbourne, Australia Donor Screening in The Region Vincini GA NRL, Melbourne, Australia NRL Established in 1985 Not-for-profit organisation that exists to support laboratories that perform testing for the diagnosis and management

More information

BLOOD SAFETY STATUS IN INDONESIA. Yuyun Soedarmono Chairman of the Indonesian Association of Transfusion Medicine

BLOOD SAFETY STATUS IN INDONESIA. Yuyun Soedarmono Chairman of the Indonesian Association of Transfusion Medicine BLOOD SAFETY STATUS IN INDONESIA Yuyun Soedarmono Chairman of the Indonesian Association of Transfusion Medicine OUTLINE Background Blood services in Indonesia Regulation related to blood safety in Indonesia

More information

Non-reproductive tissues and cells

Non-reproductive tissues and cells Colour key Minimum requirements as set out in Directive 2004/23/EC More stringent - legy binding on national level More stringent - recommended on national level Not legy binding and not recommended on

More information

Non-reproductive tissues and cells

Non-reproductive tissues and cells Colour key Minimum requirements as set out in Directive 2004/23/EC and its technical Directives (particularly 2006/17/EC) More stringent -legally binding, applies for all donations and all donor profiles

More information

Public Health, Infections and Transplantation

Public Health, Infections and Transplantation Public Health, Infections and Transplantation Dr Kerry Chant Chief Health Officer & Deputy Director General Population and Public Health NSW Ministry of Health May2014 Public Health Infection and Transplantation

More information

HEPATITIS SCREENING IN THE LITHUANIAN BLOOD ESTABLISHMENTS. Joana Bikulčienė Director of National blood center

HEPATITIS SCREENING IN THE LITHUANIAN BLOOD ESTABLISHMENTS. Joana Bikulčienė Director of National blood center HEPATITIS SCREENING IN THE LITHUANIAN BLOOD ESTABLISHMENTS Joana Bikulčienė Director of National blood center j.bikulciene@kraujodonoryste.lt Organizational structure of Lithuanian blood service 1 specialized

More information

Non-reproductive tissues and cells Recommending authority/ association

Non-reproductive tissues and cells Recommending authority/ association Colour key Minimum requirements as set out in Directive 2004/23/EC More stringent - legy binding More stringent - recommended Not legy binding and not recommended Non-reproductive tissues and cells VIRAL

More information

The Counselling of Blood Donors Identified as HIV Reactive. A Review as from January 2007 until June 2011

The Counselling of Blood Donors Identified as HIV Reactive. A Review as from January 2007 until June 2011 The Counselling of Blood Donors Identified as HIV Reactive A Review as from January 2007 until June 2011 The Blood Transfusion Service of Namibia Dr. Regine Redecker Mr. Tinus Matyayi 2 3 Background -TTI

More information

Laboratory diagnostics of blood-borne infections related to blood transfusions and transplantations

Laboratory diagnostics of blood-borne infections related to blood transfusions and transplantations 26 th Symposium Croatian Society of Medical Biochemistry and Laboratory Medicine Laboratory diagnostics of blood-borne infections related to blood transfusions and transplantations Croatian Institute of

More information

Reporting from Council of Europe member states on the collection, testing and use of blood and blood components in Europe The 2006 Survey

Reporting from Council of Europe member states on the collection, testing and use of blood and blood components in Europe The 2006 Survey Reporting from Council of Europe member states on the collection, testing and use of blood and blood components in Europe The 2006 Survey This questionnaire consists of three sections: A. Collection and

More information

The Technical Aspects of Pathogen Testing in Canada. Nancy Angus Canadian Blood Services Director, Testing

The Technical Aspects of Pathogen Testing in Canada. Nancy Angus Canadian Blood Services Director, Testing PERMISSON TO USE: Please note that, by making their presentations available on-line, primary authors have agreed to share their presentations. However, should you want to use some of the data or slides

More information

Schedule of Accreditation

Schedule of Accreditation Schedule of Accreditation Organisation Name National Virus Reference Laboratory INAB Reg No 326MT Contact Name Eimear Malone Address University College Dublin, Belfield, Dublin Contact Phone No 01-7161319

More information

Transfusion Medicine in Saudi Arabia

Transfusion Medicine in Saudi Arabia Transfusion Medicine in audi Arabia, Mc, FRCPath, CTM Director of Blood Transfusion ervices Associate Professor in Haematology KAUH, Jeddah, audi Arabia Total Area1,960,582.00 sq Population27,019,731 (2006

More information

Il ruolo delle VEQ per la sicurezza trasfusionale

Il ruolo delle VEQ per la sicurezza trasfusionale Il ruolo delle VEQ per la sicurezza trasfusionale The role of EQA for transfusion safety Giulio Pisani CNCF Ist. Sup. Sanità Global Blood Product Safety, Roma 10 aprile 2019 Blood transfusion is an essential

More information

Non-reproductive tissues and cells Recommending authority/ association

Non-reproductive tissues and cells Recommending authority/ association Colour key Minimum requirements as set out in Directive 2004/23/EC More stringent testing - legy binding on national level More stringent testing - recomd on national level Not legy binding and not recomd

More information

QUALITY CONTROL Infectious Disease

QUALITY CONTROL Infectious Disease QUALITY CONTROL Infectious Disease 1 Infectious Disease Quality Control The human based material used in the production of our Quality Controls is sourced from the Taiwan Blood Services Foundation (TBSF).

More information

Epidemiology of blood-borne Infections in Vietnam

Epidemiology of blood-borne Infections in Vietnam IPFA 4 th Asia Workshop on Plasma Quality and Supply Epidemiology of blood-borne Infections in Vietnam Nguyen Thị Lan Anh MD, PhD Center for Bio-Medical Rsearch Screening donated blood for infections:

More information

Study of ChLIA and ELISA for TTI Markers in Blood Donors

Study of ChLIA and ELISA for TTI Markers in Blood Donors Study of ChLIA and ELISA for TTI Markers in Blood Donors Presenting Author - Miss Kiran Kachhadiya (Co-authors: Dr. Vachhani N., Mrs. Bhatt J, Dr. Jani F., Dr. Nandani S.) Life Blood Centre (Formerly known

More information

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Royal Liverpool & Broadgreen University Hospitals NHS Trust Department of Virology Liverpool Clinical Laboratories Royal Liverpool and Broadgreen

More information

The Alphabet Soup of Viral Hepatitis Testing

The Alphabet Soup of Viral Hepatitis Testing The Alphabet Soup of Viral Hepatitis Testing August 18, 2011 Patricia Slev, PhD, DABCC Medical Director, Serologic Hepatitis and Retrovirus Laboratory, ARUP Laboratories Assistant Professor of Pathology,

More information

Viral hepatitis. Supervised by: Dr.Gaith. presented by: Shaima a & Anas & Ala a

Viral hepatitis. Supervised by: Dr.Gaith. presented by: Shaima a & Anas & Ala a Viral hepatitis Supervised by: Dr.Gaith presented by: Shaima a & Anas & Ala a Etiology Common: Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Less common: Cytomegalovirus EBV Rare: Herpes

More information

2014/LSIF/PD/025 Malaysia s Approach to Testing Strategies

2014/LSIF/PD/025 Malaysia s Approach to Testing Strategies 2014/LSIF/PD/025 Malaysia s Approach to Testing Strategies Submitted by: Malaysia Policy Dialogue and Workshop on Attaining a Safe and Sustainable Blood Supply Chain Manila, Philippines 30 September 1

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Advisement for the Use of Gen-Probe Procleix Ultrio Plus Assay for NAT Testing on Cadaveric Donors Release Date: 08/03/14 American Medical Education and Research Association 4757

More information

NAT Screening of Blood Donations in NBC, TRCS

NAT Screening of Blood Donations in NBC, TRCS IPFA/PEI, Italy NAT Screening of Blood Donations in NBC, TRCS 2000-2001 Clinical evaluation using COBAS AmpliiScreen HIV & HCV assays, (MP24) window period rate - 1 : 108,768 for HIV-1 and HCV 2002 Routine

More information

Single donator specimens as advantage in external quality control assessments of infectious diseases

Single donator specimens as advantage in external quality control assessments of infectious diseases Single donator specimens as advantage in external quality control assessments of infectious diseases MD, PhD Maija Lappalainen and MD Jukka Suni HUSLAB, Department of Virology Labquality Days 10.2.2007

More information

Laboratory Diagnosis of Viral Infections. G. Jamjoom 2005

Laboratory Diagnosis of Viral Infections. G. Jamjoom 2005 Laboratory Diagnosis of Viral Infections G. Jamjoom 2005 Five Main Techniques: Virus Culture and Isolation Serology Rapid Detection of Viral Antigens Detection of Viral Nucleic Acid Electron Microscopy

More information

Duration: 12 months May to April

Duration: 12 months May to April SPECIALIST CERTIFICATE IN TRANSFUSION SCIENCE PRACTICE PROGRAMME OF STUDY OVERVIEW Example only Duration: 12 months May to April This document serves as a general programme overview only. To ensure you

More information

Non-reproductive tissues and cells

Non-reproductive tissues and cells Colour key Minimum requirements as set out in Directive 2004/23/EC More stringent testing - legally binding on national level More stringent testing - recommended on national level Not legally binding

More information

Viral Hepatitis in Blood Donors

Viral Hepatitis in Blood Donors Viral Hepatitis in Blood Donors VHPB country meeting Prof Asc.Vjollca Durro Microbiology Service Medicine Faculty, Medical University Tirana, 27-28 OCTOBER 2016 1 Transfusion-transmitted viral infections

More information

Screening Donated Blood for Transfusion Transmissible Infections in Bangladesh

Screening Donated Blood for Transfusion Transmissible Infections in Bangladesh Screening Donated Blood for Transfusion Transmissible Infections in Bangladesh National Guidelines 2013 Foreword Mandatory screening of donated blood for transfusion in Bangladesh began in 2000 after implementation

More information

Robert G. Gish MD UC San Diego

Robert G. Gish MD UC San Diego Robert G. Gish MD UC San Diego The Pipeline of HIV-Related Point-Of- Care Tests is Growing Viral detection Examples: 2012 2013 2014 2015 2016 2017 CD4 test Examples: 2009 2010 2011 2012 2013 0 2014 Evidence

More information

Negative Hepatitis C Reporting and Linkage to Care Outreach

Negative Hepatitis C Reporting and Linkage to Care Outreach Negative Hepatitis C Reporting and Linkage to Care Outreach NASTAD 7 th National Hepatitis Technical Assistance Meeting November 28-30, 2017 Angelica Bocour, MPH Director of Viral Hepatitis Surveillance

More information

Answering your daily challenges. in the ELISA technology I N FECTI OUS DISEASES. bioelisa

Answering your daily challenges. in the ELISA technology I N FECTI OUS DISEASES. bioelisa Answering your daily challenges in the ELISA technology I N FECTI OUS DISEASES bioelisa RETROVIRUS HIV is the cause of the most important global pandemic. Due to the lack of vaccination, early diagnosis

More information

Within 14 days at 2-8⁰C. DO NOT FREEZE WHOLE BLOOD Micro Typing Systems 50 µl plasma

Within 14 days at 2-8⁰C. DO NOT FREEZE WHOLE BLOOD Micro Typing Systems 50 µl plasma Test Name *Minimum Collection Tubes Sample Stability ABO/Rh Blood Typing 50 µl cells EDTA whole blood (lavender-top) Within 14 days at 2-8⁰C. DO NOT FREEZE WHOLE BLOOD Micro Typing Systems 50 µl plasma

More information

Human tissues and cells annual report 2011

Human tissues and cells annual report 2011 Human tissues and cells annual report 2011 2012 Human tissues and cells Annual report Danish Health and Medicines Authority, 2012. This publication can be freely cited with a clear indication of source.

More information

Probability of false initial and repeat ID-NAT reactive donations. Marion Vermeulen IPFA Rome 2014

Probability of false initial and repeat ID-NAT reactive donations. Marion Vermeulen IPFA Rome 2014 Probability of false initial and repeat ID-NAT reactive donations Marion Vermeulen IPFA Rome 2014 Overview of SANBS SANBS is a non profit organization Provides a vein to vein blood transfusion service

More information

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK West of Scotland Specialist Virology Centre New Lister Building Level 5 Glasgow Royal Infirmary 10-16 Alexandra Parade Glasgow G31 2ER Contact:

More information

Guide to the preparation, use and quality assurance of blood components

Guide to the preparation, use and quality assurance of blood components Contents Foreword...3 Members of the European Committee (Partial Agreement) on Blood Transfusion... 8 Members of the GTS working group... 22 Members of the TS066 working group... 30 Recommendation No.

More information

Controls & Calibrators. Disease Quality Controls

Controls & Calibrators. Disease Quality Controls Controls & Calibrators Infectious Disease Quality Controls Infectious Disease Quality Controls A broad selection of controls designed to monitor assay precision of hepatitis, retrovirus, sexually transmitted

More information

Directed Semen Donor Eligibility Requirements

Directed Semen Donor Eligibility Requirements Directed Semen Donor Eligibility Requirements Directed (known) reproductive donors using the University Andrology Sperm Banking Program must follow FDA requirements to prevent the transmission of relevant

More information

seroprevalence of infectious markers & their trends in blood donors in a hospital based blood bank in north india

seroprevalence of infectious markers & their trends in blood donors in a hospital based blood bank in north india Indian J Med Res 142, September 2015, pp 317-322 DOI:1103/0971-5916.166598 seroprevalence of infectious markers & their trends in blood donors in a hospital based blood bank in north india R.N. Makroo,

More information

الحترمونا من خري الدعاء

الحترمونا من خري الدعاء الحترمونا من خري الدعاء Instructions for candidates The examination consists of 30 multiple choice questions, each divided into 5 different parts. Each part contains a statement which could be true or

More information

United Kingdom National External Quality Assessment Service for Microbiology [Established 1971]

United Kingdom National External Quality Assessment Service for Microbiology [Established 1971] United Kingdom National External Quality Assessment Service for Microbiology [Established 97] UK NEQAS covers Andrology Chemistry Genetics Haematology Histopathology Immunology Leucocyte Immunophenotyping

More information

Frequency of occult hepatitis B in HBsAg seronegative blood donors in a tertiary care hospital in kerala,south India.

Frequency of occult hepatitis B in HBsAg seronegative blood donors in a tertiary care hospital in kerala,south India. Frequency of occult hepatitis B in HBsAg seronegative blood donors in a tertiary care hospital in kerala,south India. Cinzia Keechilot, Veena Shenoy 1,V Anil kumar 2,Lalita Biswas 3. MBBS student * Transfusion

More information

The establishment of well-organized, nationally-coordinated blood transfusion services with quality systems in all areas

The establishment of well-organized, nationally-coordinated blood transfusion services with quality systems in all areas Blood Safety Global Database on Blood Safety (GDBS) 2013 The World Health Organization (WHO) programme on Blood Transfusion Safety would appreciate your kind cooperation in completing this data collection

More information

A. Anti-HIV-1/2, HIV NAT Lookback: for those identified blood and blood components collected:

A. Anti-HIV-1/2, HIV NAT Lookback: for those identified blood and blood components collected: PURPOSE: MATERIALS: To outline a procedure for removing, recalling and/or correcting blood products that do not meet the requirements of the FDA, AABB, or the blood center. Recall/Market Withdrawal Form

More information

TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES ADVISORY COMMITTEE MEETING October2010. Issue Summary

TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES ADVISORY COMMITTEE MEETING October2010. Issue Summary TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES ADVISORY COMMITTEE MEETING 28-29October2010 Issue Summary Informational Topic: FDA s Geographic Donor Deferral Policy to Reduce the Possible Risk of Transmission

More information

MP Biomedicals Asia Pacific Pte. Ltd. (formerly Genelabs Diagnostics Pte. Ltd.)

MP Biomedicals Asia Pacific Pte. Ltd. (formerly Genelabs Diagnostics Pte. Ltd.) Revision: 12 May 2005 1 WESTERN BLOT / IMMUNOBLOT HIV-1 BLOT Version 1.3* 11010-018 HIV-1 viral lysate Western Blot assay for the 11010-036 detection of antibodies to HIV-1 with serum 11010-108 108 strips

More information

Inspections, Compliance, Enforcement, and Criminal Investigations. Central Texas Regional Blood & Tissue Center 07-Nov-03

Inspections, Compliance, Enforcement, and Criminal Investigations. Central Texas Regional Blood & Tissue Center 07-Nov-03 1 of 7 6/10/2009 2:20 PM Inspections, Compliance, Enforcement, and Criminal Investigations Department of Health and Human Services Public Health Service Food and Drug Administration Dallas District 4040

More information

Viral Hepatitis Diagnosis and Management

Viral Hepatitis Diagnosis and Management Viral Hepatitis Diagnosis and Management CLINICAL BACKGROUND Viral hepatitis is a relatively common disease (25 per 100,000 individuals in the United States) caused by a diverse group of hepatotropic agents

More information

The New Regulations - Special IVD Issues

The New Regulations - Special IVD Issues The New Regulations - Special IVD Issues Dirk Stynen, Ph. D. President - Principal Consultant Qarad Geel, Belgium RMD Brussels October 2018 The IVD Regulation 2017/746 October 29, 2018 www.qarad.com 2

More information

Maximizing Cornea and Tissue Donation through Specimen Quality

Maximizing Cornea and Tissue Donation through Specimen Quality Maximizing Cornea and Tissue Donation through Specimen Quality Robert W. Bresler, Sydney D. Gastreich, Elias G. Koulouriotis, Linda S. Martin, Susan Diane Brockmeier, Chak-Sum Ho, PhD Abstract Purpose:

More information

Impact of multi-dye multiplex technology on testing algorithm

Impact of multi-dye multiplex technology on testing algorithm Impact of multi-dye multiplex technology on testing algorithm Lydia Blanco. Mª Isabel Gonzalez-Fraile Centro de Hemoterapia y Hemodonación de Castilla y León, España TTI EPIDEMIOLOGICAL DATA IN SPAIN NAT

More information

Transfusion Medicine (Comprehensive, Limited) J, J1

Transfusion Medicine (Comprehensive, Limited) J, J1 www.cap.org Transfusion Medicine Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS). Transfusion Medicine (Comprehensive, Limited)

More information

Primary Sample Manual Infectious Serology Issue No Effective Date: 20/09/17 Page 1 of 15 EUROFINS BIOMNIS

Primary Sample Manual Infectious Serology Issue No Effective Date: 20/09/17 Page 1 of 15 EUROFINS BIOMNIS Issue No. 2.02 Effective Date: 20/09/17 Page 1 of 15 Written / Revised By: Dr. Mike Louw, Medical Director Date: Reviewed By: Date: Dr. Sinead Kelly, Infectious Serology Consultant Authorised By: Jean-Sébastien

More information

Transfusion Transmissible Infections among Voluntary Blood Donors at the University Teaching Hospital, Lusaka, Zambia

Transfusion Transmissible Infections among Voluntary Blood Donors at the University Teaching Hospital, Lusaka, Zambia ORIGINAL ARTICLE Transfusion Transmissible Infections among Voluntary Blood Donors at the University Teaching Hospital, Lusaka, Zambia,2,3 2 3 3 D Chama, Y Ahmed, KS Baboo, H Halwindi, J Mulenga, 2 Zambia

More information

Increasing syphilis notifications in Mongolia: results from national surveillance for

Increasing syphilis notifications in Mongolia: results from national surveillance for Increasing syphilis notifications in Mongolia: results from national surveillance for 21 211 Surveillance Report Jantsansengeegiin Baigalmaa, ab Choijiljaviin Erdenechimeg, a Jadambaagiin Narantuya, c

More information

HEPATITIS B AND HEPATITIS C VIRUS AMONG BLOOD DONORS

HEPATITIS B AND HEPATITIS C VIRUS AMONG BLOOD DONORS HEPATITIS B AND HEPATITIS C VIRUS AMONG BLOOD DONORS VIRAL HEPATITIS PREVENTION BOARD MEETING LISBON, PORTUGAL, 18 19 November 2010 Gabriel de Olim Presidente do Conselho Directivo do Instituto Português

More information

Plasma for fractionation: South African Plasma Requirements

Plasma for fractionation: South African Plasma Requirements Plasma for fractionation: South African Plasma Requirements Dr Jeh-han Omarjee Head: Microbiological Sciences NBI is a "not for profit" company committed to providing safe, cost effective, quality medicinal

More information

RESOLUTION OF THE STATE GREAT KHURAL OF MONGOLIA. 11 October 2002 No: 68 Ulaanbaatar. Adoption of the Government Policy on Drugs

RESOLUTION OF THE STATE GREAT KHURAL OF MONGOLIA. 11 October 2002 No: 68 Ulaanbaatar. Adoption of the Government Policy on Drugs Translation from Mongolian RESOLUTION OF THE STATE GREAT KHURAL OF MONGOLIA 11 October 2002 No: 68 Ulaanbaatar Adoption of the Government Policy on Drugs The State Great Khural of Mongolia RESOLVES: 1.

More information

Database on Blood Safety 2009 in ECO Member States

Database on Blood Safety 2009 in ECO Member States Database on Blood Safety 2009 in ECO Member States Section 1: Administrative Information Information provided by: 1.1 Name: 1.2 Title: 1.3 Position: 1.4 Organization: 1.5 Address: 1.6 Country: 1.7 Tel.

More information

transfusion-transmissible HCV and HIV in Italy Haemovigilance and the residual risk of

transfusion-transmissible HCV and HIV in Italy Haemovigilance and the residual risk of Haemovigilance and the residual risk of transfusion-transmissible Giuliano Grazzini, MD National Blood Centre, National Institute of Health, Rome, Italy & International Federation of Blood Donor Organizations

More information

Routine Use of Mini-Pool Nucleic Acid Testing (MP-NAT) Multiplex Assay for Sero-Negative Blood Donors

Routine Use of Mini-Pool Nucleic Acid Testing (MP-NAT) Multiplex Assay for Sero-Negative Blood Donors Journal of the Egyptian Society of Haematology & Research, Vol. 7, No. 2, September: 1-5, 2011 Routine Use of Mini-Pool Nucleic Acid Testing (MP-NAT) Multiplex Assay for Sero-Negative Blood Donors HISHAM

More information

The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations Jackson B R, Busch M P, Stramer S L, AuBuchon J P

The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations Jackson B R, Busch M P, Stramer S L, AuBuchon J P The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations Jackson B R, Busch M P, Stramer S L, AuBuchon J P Record Status This is a critical abstract of an economic evaluation that meets

More information

Diagnostic Methods of HBV and HDV infections

Diagnostic Methods of HBV and HDV infections Diagnostic Methods of HBV and HDV infections Zohreh Sharifi,ph.D Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine Hepatitis B-laboratory diagnosis Detection

More information

Microbiology EQA Product Portfolio

Microbiology EQA Product Portfolio Labquality EQAS Microbiology EQA Product Portfolio Clinically relevant external quality assessment program for microbiology Bacterial serology Bacteriology Mycology Parasitology Preanalytics Virology Labquality

More information

An STBBI Testing Update and the Quest for the 300

An STBBI Testing Update and the Quest for the 300 An STBBI Testing Update and the Quest for the 300 Jared Bullard MD FRCPC Paediatric Infectious Diseases & Medical Microbiology Associate Medical Director Cadham Provincial Laboratory WRHA STBBI Conference

More information

risk of Transfusion-Transmitted Transmitted Viral Infections (HIV, HCV and HBV)

risk of Transfusion-Transmitted Transmitted Viral Infections (HIV, HCV and HBV) Prevention and ResidualR risk of Transfusion-Transmitted Transmitted Viral Infections (HIV, HCV and HBV) Syria Laperche L (Centre National de référence r rence pour les hépatites h B et C en Transfusion)

More information

QSEAL Recovered Plasma Specification

QSEAL Recovered Plasma Specification QSEAL Recovered Plasma Specification Background The is part of a series of standards that comprise the Plasma Protein Therapeutics Association (PPTA) QSEAL Standards Program. PPTA's Voluntary Standards

More information

Overview of Blood Transfusion System of Iran:

Overview of Blood Transfusion System of Iran: Report Article Overview of Blood Transfusion System of Iran: 2002-2011 AM Cheraghali High Institute for Research and Education on Transfusion Medicine, Iran Blood Transfusion Organization and University

More information

HIV Testing and Systems for Managing HIV Implementation in Resource Limited Settings

HIV Testing and Systems for Managing HIV Implementation in Resource Limited Settings HIV Testing and Systems for Managing HIV Implementation in Resource Limited Settings Elizabeth M. Dax with the staff of the National Serology Reference Laboratory, Australia My Background Worked in HIV

More information

Khalid Alquthami (Correspondence) Regional Lab, Makkah. Saudi Arabia

Khalid Alquthami (Correspondence) Regional Lab, Makkah. Saudi Arabia 1 Regional Lab, Makkah. Saudi Arabia stract: Clinical specificity and genotype/subtype detection of viruses using the Cobas TaqScreen MPX system V 2.0, which is a nucleic acid test (NAT) that uses multiples

More information

We are pleased to present the new Leaflet bioelisa Menu and Instrumentation, with reference

We are pleased to present the new Leaflet bioelisa Menu and Instrumentation, with reference NEWS BK NEWS# 390/ MKT DATE : 13-07-2016 TITLE : New Leaflet bioelisa Menu and Instrumentation Dear colleagues, We are pleased to present the new Leaflet bioelisa Menu and Instrumentation, with reference

More information

Diagnostic Methods of HBV infection. Zohreh Sharifi,ph.D of Virology Research center, Iranian Blood Transfusion Organization (IBTO)

Diagnostic Methods of HBV infection. Zohreh Sharifi,ph.D of Virology Research center, Iranian Blood Transfusion Organization (IBTO) Diagnostic Methods of HBV infection Zohreh Sharifi,ph.D of Virology Research center, Iranian Blood Transfusion Organization (IBTO) Hepatitis B-laboratory diagnosis Detection of HBV infection involves

More information

Optimal / Evidence-based Method to Prevent Transmission of Cytomegalovirus (CMV) by Transfusion

Optimal / Evidence-based Method to Prevent Transmission of Cytomegalovirus (CMV) by Transfusion ILABB Fall Meeting 2015 Optimal / Evidence-based Method to Prevent Transmission of Cytomegalovirus (CMV) by Transfusion Presenter Ronald G Strauss, MD Associate Medical Director, LifeSource/ITxM Terms

More information

LAW OF MONGOLIA. 13 May 2004 Ulaanbaatar LAW ON PREVENTION OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION, AND ACQUIRED IMMUNE DEFICIENCY SYNDROME

LAW OF MONGOLIA. 13 May 2004 Ulaanbaatar LAW ON PREVENTION OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION, AND ACQUIRED IMMUNE DEFICIENCY SYNDROME LAW OF MONGOLIA 13 May 2004 Ulaanbaatar LAW ON PREVENTION OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION, AND ACQUIRED IMMUNE DEFICIENCY SYNDROME CHAPTER ONE General Provisions Article 1. Purpose of the Law

More information

Version for the Silent Procedure 29 April Agenda item January Hepatitis

Version for the Silent Procedure 29 April Agenda item January Hepatitis Version for the Silent Procedure 29 April 2014 134th session EB134.R18 Agenda item 10.5 25 January 2014 Hepatitis The Executive Board, Having considered the report on hepatitis, 1 RECOMMENDS to the Sixty-seventh

More information

UGANDA POPULATION-BASED HIV IMPACT ASSESSMENT UPHIA

UGANDA POPULATION-BASED HIV IMPACT ASSESSMENT UPHIA EXTENDED SUMMARY SHEET: PRELIMINARY FINDINGS APRIL 018 UGANDA POPULATION-BASED HIV IMPACT ASSESSMENT UPHIA 016 017 The Uganda Population-based HIV Impact Assessment (UPHIA), a household-based national

More information

NEWS BK NEWS # 378 /MKT DATE : TITLE. Dear colleagues,

NEWS BK NEWS # 378 /MKT DATE : TITLE. Dear colleagues, 1 NEWS BK NEWS # 378 /MKT DATE : 16022016 TITLE : New Bioelisa reagents Brochures Dear colleagues, We are pleased to present the new Bioelisa reagents Brochures, which are a very useful marketing and selling

More information

Increased Risk Donors for Organ Transplantation

Increased Risk Donors for Organ Transplantation A Tool Kit to Assist Transplant Programs in the Use of Increased Risk Donors for Organ Transplantation February 2016 Table of Contents Table of Contents... 2 1.0 Increased Risk Donor Tool Kit... 3 1.1

More information

Trends in molecular diagnostics

Trends in molecular diagnostics Trends in molecular diagnostics Detection of target genes of interest Quantification Infectious diseases HIV Hepatitis C & B TB / MAC Cytomegalovirus Herpes simplex Varicella zoster CT/GC HPV Profiling

More information

Case 1. FDA, Legal, and EBAA Medical Standards Panel. Case 1. Case 1 6/25/2012. Samuel B. Barone, M.D. Office of Cellular, Tissue, and Gene Therapies

Case 1. FDA, Legal, and EBAA Medical Standards Panel. Case 1. Case 1 6/25/2012. Samuel B. Barone, M.D. Office of Cellular, Tissue, and Gene Therapies Case 1 FDA, Legal, and EBAA Medical Standards Panel Samuel B. Barone, M.D. Office of Cellular, Tissue, and Gene Therapies Medical Directors Symposium Eye Bank Association of America Annual Meeting 47 y/o

More information

Memo No: Date: 25-Nov NEW Serology and Virology Testing

Memo No: Date: 25-Nov NEW Serology and Virology Testing Memo No: 2014-61 Date: 25-Nov-2014 www.hicl.on.ca Re: NEW Serology and Virology Testing In Common Laboratories has been working hard to expand our test menu. We are pleased to announce the availability

More information

patients with blood borne viruses Controlled Document Number: Version Number: 4 Controlled Document Sponsor: Controlled Document Lead:

patients with blood borne viruses Controlled Document Number: Version Number: 4 Controlled Document Sponsor: Controlled Document Lead: CONTROLLED DOCUMENT Procedure for the management of patients with blood borne viruses CATEGORY: CLASSIFICATION: PURPOSE Controlled Document Number: Version Number: 4 Controlled Document Sponsor: Controlled

More information

Fact Sheet Blood Collection and Use Hong Kong Red Cross Blood Transfusion Service The Hong Kong Red Cross began its voluntary, nonremunerated blood donation programme to supply blood to all hospitals in

More information

NRL EQAS for NAT: Assessing the variability and performance of molecular assays for clinical pathogens

NRL EQAS for NAT: Assessing the variability and performance of molecular assays for clinical pathogens NRL EQAS for NAT: Assessing the variability and performance of molecular assays for clinical pathogens Vincini GA*, Cabuang LM, Land S, Best SJ NRL London, 12 January 2011 NRL EQAS for NAT HCV Genotyping

More information

HUNGARIAN NATIONAL BLOOD TRANSFUSION SERVICE. Dr. Klara Baroti-Tóth, PhD IPFA/PEI 19 th International Workshop Budapest, May, 2012.

HUNGARIAN NATIONAL BLOOD TRANSFUSION SERVICE. Dr. Klara Baroti-Tóth, PhD IPFA/PEI 19 th International Workshop Budapest, May, 2012. HUNGARIAN NATIONAL BLOOD TRANSFUSION SERVICE Dr. Klara Baroti-Tóth, PhD IPFA/PEI 19 th International Workshop Budapest, 23-24 May, 212. BLOOD DONATION G I V I N G I S G O O D ORGAN COORDINATION OFFICE

More information

The testing of Donated Blood and Components at NHSBT

The testing of Donated Blood and Components at NHSBT The testing of Donated Blood and Components at NHSBT NHSBT is responsible for collecting all donated blood and platelets in England, then processing into components before issuing to client hospitals.

More information